Literature DB >> 17177654

Cancer mortality, recent trends and perspectives.

Dragana Niksić1, Amira Kurspahić-Mujicić, Aida Pilav, Haris Niksić.   

Abstract

Considering that a register for cancer was established in Federation of Bosnia and Herzegovina only recently, basic reliable source for the analysis of cancer mortality trends are the data on death cases caused by such diseases. Lack of census as well as standardized mortality rate data makes the study even more difficult to make. The aim of the study is the analysis of the malign diseases trend in the post-war period according to the available data. The study is the descriptive work on the analysis of the system using linear regression methods for expected trend for the total population and age group from 0 to 64 years. Registered rate of cancer mortality in Federation of Bosnia and Herzegovina in 2004 was 142 per 100000 inhabitants, and indicates input stream in the analyzed period. Total increase in mortality of males and females is 2.5% per year. It is expected that in 2020 around 5000 inhabitants of Federation of Bosnia and Herzegovina will die of some malign disease. Trend of mortality of malign diseases in males is higher than in females and more probable in older population. There is a tendency of mortality decrease in the group of 0-64 years of age. Mortality list of the most frequent locations of cancer has undergone changes. Liver cancer, colon cancer, sigma and rectum cancer as well as lung and breast cancer lead the list. Objective ageing of the population, technological drawbacks, insufficient primary and secondary prevention worsened by socio-economic life conditions will affect the increase in number of people with malign diseases in Bosnia and Herzegovina.

Entities:  

Mesh:

Year:  2006        PMID: 17177654      PMCID: PMC5807974          DOI: 10.17305/bjbms.2006.3125

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  12 in total

1.  Inequalities in health in Europe.

Authors:  F Levi; F Lucchini; S Franceschi; E Negri; C La Vecchia
Journal:  BMJ       Date:  2001-03-31

2.  Cancer--nature, nurture, or both.

Authors:  R N Hoover
Journal:  N Engl J Med       Date:  2000-07-13       Impact factor: 91.245

3.  Sex differences in colorectal cancer mortality in Europe, 1955-1996.

Authors:  E Fernandez; C Bosetti; C La Vecchia; F Levi; F Fioretti; E Negri
Journal:  Eur J Cancer Prev       Date:  2000-04       Impact factor: 2.497

4.  Trends and patterns of cancer mortality in European countries.

Authors:  J L F Antunes; T N Toporcov; F P de Andrade
Journal:  Eur J Cancer Prev       Date:  2003-10       Impact factor: 2.497

5.  Lung cancer mortality in European women: recent trends and perspectives.

Authors:  C Bosetti; F Levi; F Lucchini; E Negri; C La Vecchia
Journal:  Ann Oncol       Date:  2005-07-13       Impact factor: 32.976

6.  Is the war on cancer being won?

Authors:  G Kolata
Journal:  Science       Date:  1985-08-09       Impact factor: 47.728

7.  Mortality from major cancer sites in the European Union, 1955-1998.

Authors:  F Levi; F Lucchini; E Negri; P Boyle; C La Vecchia
Journal:  Ann Oncol       Date:  2003-03       Impact factor: 32.976

8.  Going up or coming down? The changing phases of the lung cancer epidemic from 1967 to 1999 in the 15 European Union countries.

Authors:  F Bray; J E Tyczynski; D M Parkin
Journal:  Eur J Cancer       Date:  2004-01       Impact factor: 9.162

9.  Cancer mortality in Europe: effects of age, cohort of birth and period of death.

Authors:  C La Vecchia; E Negri; F Levi; A Decarli; P Boyle
Journal:  Eur J Cancer       Date:  1998-01       Impact factor: 9.162

10.  On the use of familial aggregation in population-based case probands for calculating penetrance.

Authors:  Colin B Begg
Journal:  J Natl Cancer Inst       Date:  2002-08-21       Impact factor: 13.506

View more
  1 in total

1.  Single centre experience with Excluder® stent graft; 17-year outcome.

Authors:  Ziga Snoj; Tjasa Tomazin; Vladka Salapura; Dimitrij Kuhelj
Journal:  Radiol Oncol       Date:  2022-04-13       Impact factor: 4.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.